Ras the GTPase
Ras is a 21kDa monomelic GTPase that cycles between the active GTP state and inactive GDP state. The intrinsic GTPase activity of Ras is very poor, hydrolyzing GTP at a rate of about lO'V 1 . The GTPase activity is accelerated 10 5 fold by the GTPase activating protein (GAP). Because the level of GTP in the cell is nearly 10 times that of GDP, Ras will naturally be bound to GTP. In order to accelerate the exchange of GDP for GTP, guanine nucleotide exchange factor (GET), is required to dissociate the GDP. The three structural regions involved in GTPase activity are: the P-Loop, switch 1 and switch 2. The amino acid mutations of G12V and Q61L occur in the P-Loop and switch 2 regions, respectively. It is these mutations that hinder the GTPase acitivity and incur upon Ras its oncogenic properties [12] .
Ras effectors
When Ras is bound to GTP it is able to associate with its effectors. The most studied pathway to date has been the mitogen-activated protein kinase/extracellular regulated kinase (MAPK/Erk) cascade. The MAPK, p42 and p44, are known as Erkl and Erk2 respectively and are so similar that they are considered nearly functionally identical [13] . The main components of the MAPK cascade consist of Raf-1, MAP/Erk kinase (MEK) and Erkl/2.
The GTP bound Ras protein binds Raf-1 via its Ras binding domain (RBD). Raf-1, a serine/threonine kinase, then phosphorylates and activates MEK. MEK, a dual specificity tyrosine/threonine kinase, phosphorylates and activates Erkl and Erk2. Erkl and Erk2 are serine/threonine kinases that form dimers when phosphorylated and translocate to the nucleus where they phosphorylate the Ets family of transcription factors [14] . Recently, the scaffold protein kinase suppressor of Ras-1 (KSR-1) was demonstrated to be an important part of MAPK signaling. KSR-1 is able to bind Raf-1, MEK and Erk enabling a more controlled signal simply by having all of the effectors in the same area. More importantly, the scaffold protein, similar expression to FGF (fibroblast growth factor) genes (Sef), was found bound to MEK and Erk on the Golgi [15] . This added to the growing list of evidence supporting the importance of signal transduction from the Golgi.
Three other well characterized effectors of Ras are MEKK, phosphatidyl inositol-3-kinase (PI3K) and Ral GEFs. The MEKK are involved in the phosphorylation c-Jun Nterminal kinase (INK) which lead to the phosphorylation of the c-Jun transcription factor [16] . PI3K phosphorylates Akt, otherwise known as protein kinase b (PKB), which mediates antiapoptotic signals. PI3K also links the Ras pathway to Rho/Rac proteins by a mechanism that has yet been elucidated [17] . The Ral GEFs interact with Ral GTPases, a relative of Ras that is involved in activating phospholipase Dl. Some of the Ral GEFs are: Ral-GO S, RLF and Rgl [18] . A recent report has implicated Ral GO S in having a role in human oncogenesis [19] ,
Posttranslational processing
Ras begins its life in the cell by being translated on free ribosomes in the cytosol.
The C-terminal CAAX box motif is then recognized by famesyl transferase (FTPase) where it binds Ras with nanomolar affinity. The FTPase then attaches a 15 carbon isoprenoid, famesyl diphosphate, to the cysteine of the CAAX box motif via a very stable thioether bond [20] . With a lipid tethered to the C-terminus, Ras becomes a substrate for Ras and a-factor converting enzyme (Reel) a protein that resides in the ER membrane and cleaves the A AX 4 amino acids from the C-terminus of Ras [21] . Ras then proceeds to the next enzyme, isoprenylcysteine carboxyl methyltransferase (Icmt), where the a-carboxyl group on the isoprenylated cysteine is methylated with S-adenosylmethione donating the methyl group [22] , At this point the different Ras isoforms diverge. K-Ras,with its polylysine sequence in the HVR, does not require further processing and proceeds to the plasma membrane (PM) via an uncharacterized mechansim [23] . N-Ras and H-Ras are further modified by Ras palmitoyltransferase (RPT) which attaches a palmitoyl from palmitoyl-CoA to C181 on N-Ras and CI81 and CI84 on H-Ras via a labile thioester bond. Recently the mammalian RPT complex, DHHC9 (Asp-His-His-Cys motif) and GCP16 (Golgi localized protein), was identified as a palmitoyl transferase for H-Ras and N-Ras.
Immunofluorescence analysis indicated that this complex resides in the ER and the Golgi [24] . Recent studies report evidence of an acylation cycle that shuffles a depalmitoylated Ras to the Golgi to be repalmitoylated. This substantiates a mechanism of Ras palmitoylation on the Golgi [25, 26] .
Ras signaling from endosomes
Since its discovery, it was believed that Ras needs to be at the PM to signal. This paradigm was put into question in 1994. It was demonstrated that, after administering a large dose of epidermal growth factor (EGF) to rat parenchyma, the Ras effectors She, Grb2 and mSOS were isolated on early endosomes [27] . This discovery fostered the idea that epidermal growth factor receptor (EGFR) signaling may continue while the EFGR is on endosomes. The next step came through the utilization of the K44A dominant negative mutation of dynamin. Dynamin is a GTPase that regulates clathrin mediated endocytosis and the K44A mutation prevents endocytosis. It was found that MAP kinase activity was suppressed in endocytosis deficient cells containing K44A dynamin. The p85 subunit of PI3 kinase also showed a greatly reduced phosphorylation. These data lead to the conclusion that EGFR trafficking via endosomes was important to promote downstream signaling events [28] , There is direct evidence that Ras is bound to endosomes. Ras was found on purified endosomal fractions separated from rat liver [29] . Specific Ras isoform targeting to endosomes was elucidated by Jiang and Sorkin. Both H-Ras and K-Ras were found on endosomes together with their effector proteins using fusion protein based technology and fluorescence resonance energy transfer (FRET). Interestingly, the relative amount of H-Ras was higher than K-Ras on endosomes and GTP loading was not a factor. The most important tool employed was the Ras binding domain(RBD) of Raf-1 fused to YFP. Since the RBD only binds a Ras protein that is GTP loaded, the YFP-RBD was a valuable tool to gauge whether Ras was active in a cellular environment [30] .
Because the antibody probe used in the Pol experiment was not specific to H-Ras the question remained which Ras isoform was on endosomes. Hancock's group used the dynamin K44A mutant along with GFP fusion proteins of H-Ras and K-Ras to demonstrate that H-Ras and not K-Ras was dependant upon endosomal traffic in order to propagate its signal through the Raf/MEK/MAPK cascade. Unlike previous experiments that looked at EGFR stimulation, Hancock used the G12V constitutively active form of Ras to initiate Raf binding to Ras [31] , The scientific community was now fairly convinced that Ras could not only signal from a platform other than the PM, but the H-Ras isoform actually required endosomes to relay its signal through at least one of the known cascades.
Ras signaling on the ER
The C181,C184S double mutant of H-Ras is palmitoylation deficient and is limited to the ER and cytosol [23] . The first transmembrane domain of the avian infectious bronchitis virus M protein (Ml) has also been shown to be restricted to the ER because of its transmembrane sequence [32] . H-Ras61L was fused to the C-terminus of the Ml protein and it, as well as, the 61L version of the C181S, C184S double mutant were transfected into NIH- (H-Ras with only the Q61L mutation) but higher than vector alone. Interestingly,in the Ml mutant, the phospho-Jnk activation was greater than H-Ras61LWT or the C181S,C184S construct [33] . This data seems to point to a difference in signaling capability when H-Ras is in its natural membrane orientation, C181S, C184S mutant, versus an N-terminal tether, Ml, where the orientation of H-Ras in regards to the membrane may be completely different. In order to test whether H-Ras could be GTP loaded while residing on the ER, COS-7 cells were transiently transfected with H-Ras and stimulated with either ionomycin or lysophosphatide acid (LPA) and imaged. It was found that the Ras GEFs, RasGRFl and 2, 7 both colocalized with H-Ras, indicating GTP loading. GTP loading was also confirmed with the Ml tether and C181S,C184S mutant [34] .
These sets of experiments demonstrated that both a constitutively active, as well as, a signal activated H-Ras can signal from the ER.
H-Ras signaling from the Golgi Apparatus
With strong evidence for H-Ras signaling from both endosomes and the ER, researchers asked whether Ras could signal from the Golgi. H-Ras and N-Ras had both been shown to accumulate in the Golgi, so the idea of the Golgi as signaling platform was plausible [35] .
Golgi localized H-RasWT and H-Ras61L activity was shown in COS-1 cells. First, the cells were cotransfected with H-RasWT and GFP-RBD and stimulated with EGF. There was a distinct difference in GFP-RBD recruitment to the Golgi versus the PM. The PM recruitment was rapid, within 1-3 minutes, with a peak at 10 minutes. The Golgi recruitment was delayed, occured in 10 minutes, with continued accumulation to 60 minutes. Next phosphorylation levels of downstream effectors were compared in cells expressing either HRasôlLWT and KDELr-H-Ras61LWT. The KDEL receptor (KDELr) is a resident protein in the Golgi that traffics back to the ER. An N193D mutation in KDELr keeps it in the Golgi.
KDELr was tethered to the N-terminus of H-Ras61L. The levels of phosphorylation for the cells expressing the KDELr-H-Ras61L construct were greater in phospho-Akt and Erk when compared to cells expressing H-Ras61LWT. Phosphorylation levels of phospho-Jnk in the KDELr-H-Ras61L cells were, however, much lower than the H-Ras61LWT cells [33] . These assays established the ability of H-Ras to signal from the Golgi. H-Ras was shown to have a GEF specific to the Golgi in PC12, COS-1 and Jurkat cells. Phospholipase Cyl (PLCyl) was activated in a calcium-dependant manner that recruited RasGRPl,a Ras GEF, to the Golgi upon stimulation [36] . With the confirmation of a Golgi specific GEF for Ras, it seemed clear that Ras could signal from the Golgi in its natural state. Recently, it was reported that a Ras effector, Ras interacting protein (Rain), was Golgi specific [37] .
All assays to this point were done with transiently transfected cells, the next step was to use a stable cell line. NIH-3T3 stable cell lines were created with various membrane sitespecific proteins fused to H-RasG12V, one of which was the KDELr. Although KDELr-HRasV12 bound to RBD-GST in vitro, colocalization with endogenous c-Raf in vivo was limited. The phophorylation levels of phospho-Akt and Erk were diminished in the KDELr-H-RasV12 cells compared to the H-RasVI2 cells. Phospho-Jnk and GTP loaded Ral were both comparable in each cell type [38] . As with the Ml constructs on the ER, there seemed to be a distinct preference for signaling pathways from the Golgi.
Trafficking of C-terminal mutations in H-Ras
The C-terminus of each of the Ras isoforms is unique and it is this difference that aids in targeting each to a specific pathway and preferred compartment. Single point mutations that remove one or both of the palmitoylation sites give insights into a possible preference in the C-terminus orientation with a membrane, or the lifetime of the Ras molecule on a particular membrane. If there is a C181S mutation, leaving only the CI 84 palmitoylated, HRas will accumulate on the Golgi with very little reaching the PM. The C184S H-Ras protein is much more prevalent on the PM with some Golgi and ER accumulation as well. Notably, both mutations are equally more soluble than the wild type H-Ras, with approximately 50% of each total protein being in the soluble fraction of the cell lysates. Cells treated with [ 3 H]palmitic acid were lysed and blotted and demonstrated that each mutant did indeed have a palmitate [39] .
A C-terminus mutation of H-Ras created by Buss and colleagues changed the wild type GCMSCKCLVS to GSDQCECVLS (SDQ). The removal of the lysine and addition of glutamate and aspartate changes the overall charge on the C-terminus from +1 to -2, as well as, removing the site for 181 palmitate attachment. The work of this thesis shows that this protein has strong Golgi accumulation with none of the protein reaching the PM. As with the C181S and C184S mutations, the SDQ mutation renders the H-Ras protein much more soluble than the wild type. Though SDQ transformation was almost zero, activity could be restored by adding a leader sequence to the N-terminus that encoded a myritoylation site.
This indicated that the protein was in the correct conformation and could bind its effectors.
[ 3 H] palmitic acid labeling was also performed and illustrated that the SDQ mutant was palmitoylated [40] . The SDQ mutant therefore seems to be an excellent tool for studying HRas signaling from the Golgi.
Purpose of the SDQ mutant and this thesis
By studying signaling of the SDQ mutant we hope to ascertain a truer sense of cascades that originate from the Golgi. We believe that SDQ H-Ras presents a more natural orientation of the molecule in the cell. Whereas SDQ has been shown to be palmitoylated and is, therefore, most probably tethered to the membrane via its lipids, the KDELr-H-Ras fusion protein with its N-terminus tethered to a membrane cannot be assured to have the with poly-L-lysine (100 ^g/ml) and fibronectin ( 50 ^g/ml).
Materials and Methods

Plasmids
Immunofluorescent images
COS-7 cells were cultured and transfected as described above. NIH-3T3 cells stably expressing H-RasWT, CDQSE and SDQCE were grown on coverslips for 24 hours prior to being treated with 40 ng/ml of EGF for either 5, 30 or 60 minutes. The cells were washed in PBS twice and fixed with 4% paraformaldehyde in PBS 30 minutes at room temperature.
The cells were permeablized with -20°C methanol for 30 seconds and quenched with 50mM NH 4 C1 in PBS for 15 minutes at room temperature. Cells were then blocked with blocking buffer (0.4% BSA and 2% horse serum in PBS) for 1 hour at room temperature. Cells were then incubated in primary antibody diluted in blocking buffer for 1 hour at room temperature, rinsed 3 times in TTBS and incubated in secondary antibody another hour at room temperature . Cells were then washed in PBS and distilled water and mounted on a glass slide with mounting media (Vectashield) and adhered with regular nail polish. Untransfected cells were stained as a negative control. Each set of experiments was repeated 3 times. 
Imaging
Cells were imaged with a lOOx oil lense on a Leica DM IRE2 inverted fluorescent microscope. Images were captured with a Q Imaging Retiga 1300 camera, processed with Openlab 3.1.4 and converted to JPEG files with Adobe Photoshop 7.0. X-ray films of western blots were scanned with an HP 2300 series scanner/printer and denisometry was carried out with ImageJ.
Immunoblots
NIH-3T3 cells were cultured in 100mm tissue culture plates and treated with 40 ng/ml EGF for either 10, 30 or 60 minutes. Cells were lysed with 1.0 ml of lysis buffer (150 mM NaCl, 20 mM Tris-HCl pH 7.5, 20 mM MgCl and 0.5% NP-40) on ice and 5X SDS-PAGE loading buffer (10% SDS, 400mM Tris pH 6.8, 500 mM DTT, 10% glycerol, Bromophenol blue 0.04%) was added immediately. Samples were boiled for 10 minutes and proteins were separated by SOS-PAGE Proteins were transferred by electrophoration to a PVDF membrane and blocked with 5% milk in TTBS at room temperature for 1 hour.
Membranes were then probed with primary antibody overnight at 4°C, rinsed 3 times in TTBS and probed in secondary HRP conjugates for 1 hour at room temperature. Membranes were then rinsed 3 times in TTBS and developed with SuperSignal according to the manufacturer's protocol (Pierce). staining. SDQ is lacking a potential palmitoylation site like CI8IS, but is unable to reach the PM. SDQ has the same amino acid charge change like CDQSE, but it is able to accumulate in the ERGIC/cis-Golgi unlike the ER localization of CDQSE. The combination charge change due to amino acid mutation and lack of palmitoylation site at C181 has incurred upon SDQ its unique qualities of Golgi localization without PM localization.
Results
H-RasSDQCE is trapped on ERGIC and cis-Golgi
H-RasSDQCE can be GTP loaded on the Golgi after EGF stimulation
The next test was to determine whether SDQ could be GTP loaded on the Golgi. The data in this thesis have contributed to the overall understanding of Ras signaling from the Golgi. The SDQ mutant appears to be an excellent tool to parse the complex signaling pathways that occur in the cell. Based on the evidence in this thesis as well as other reports, SDQ accumulates in the ERGIC/cis-Golgi region, is palmitoylated and is most probably folded in the correct conformation to be able to initiate signal cascades when bound to GTP [40, 41] . Indeed, SDQ is unique from the CDQCE, C181S and C184S mutations to the tail region of H-Ras in that it does not reach the PM. It seems that the combination of an overall change in charge from +1 to -2, coupled with a C181S mutation that eliminates a palmitoylation site, is enough to allow SDQ to traffic to the cis-Golgi and go no further.
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More importantly, this thesis as well as other reports have demonstrated that a wild type HRas will accumulate on the cis-Golgi [23, 25, 26, 31, 33 ,39] . This lends credence to idea that, in a natural setting, H-Ras will spend a great deal of time on the Golgi and the Golgi membrane may provide a suitable platform for signaling. This sustained activation of two signaling cascades is significant in greater perpetuation of the initial extra cellular stimulation. This may lead the cell to an increased probability of transformation or differentiation or an increase in growth or metabolism. Indeed, the PI3K/Akt pathway has been implicated in glucose uptake and metabolism, so the notion of a molecule that would increase glucose uptake in a time of need does not seem unlikely. Just as important, neuronal cells will differentiate and T-cells will grow when the Ras/Raf/MEK/Erk pathway is stimulated from a Golgi bound Ras [36] .
The majority of the focus on Ras signaling looks at its role in cancer. To that end many studies have implemented the constitutively active form of Ras to assess its signaling parameters [31, 33, 36, 38] . Several studies have used NIH-3T3 cells to stably express either the G12V or Q61L active versions of H-Ras with conflicting results [33, 38] , The Willumsen, etal report [40] used SDQ61L for its transformation focus formation assays with poor results. Transforming activity was restored, however, when a myristoylation leader sequence was attached to the N-terminus. This indicated that the SDQ protein was folded properly and could signal enough to cause transformation. A later study by Zheng [41] demonstrated that SDQ could transform and cause focus formation at a rate of approximately 30% of H-RasWT61L. The discrepancy was most probably due to a more robustly expressing vector having been used by Zheng. Zheng also showed that SDQ61L
could phosphorylate Erk and Akt on an order close to that of H-RasWT61L . Matallanas [38] , however, showed that with the KDELr tethered H-RasWT 12V the level of phosho-Erk activation was one tenth that of H-RasWT12V and the phospho-Akt was about a third of the WT. Matallanas also found no transforming ability when staining for focus formation. The difference in outcomes of the SDQ versus the KDELr mutants may be both in the folding and orientation of the Ras molecule as well as a biological need for Ras to cycle on and off the Golgi. Because the KDELrN193D is a integral membrane protein, it being tethered to the Nterminus of H-Ras may disrupt the normal conformation of H-Ras, reducing its affinity for Raf-1 or PI3K. Matallanas acknowledged that the N193D mutation of KDELr may account for its lack of transforming ability. Since the KDELrN193D can not cycle back to the ER, it may affect the normal sequence of signaling events. The SDQ mutant is tethered to the membrane with the correct conformation and orientation and with a higher amount being in the cytosol compared to H-RasWT, it seems to have the ability to cycle on and off the Golgi.
Indeed, studies have shown that H-Ras is deacylated at the PM and becomes reacylated at the
